New insights into the mechanisms of action of radioimmunotherapy in lymphoma. - Wikidata - wikimedia - TriplyDB

New insights into the mechanisms of action of radioimmunotherapy in lymphoma.

New insights into the mechanisms of action of radioimmunotherapy in lymphoma.

http://www.wikidata.org/entity/Q37222783

about

Improving the treatment of non-Hodgkin lymphoma with antibody-targeted radionuclides.Tumour targeting and radiation dose of radioimmunotherapy with (90)Y-rituximab in CD20+ B-cell lymphoma as predicted by (89)Zr-rituximab immuno-PET: impact of preloading with unlabelled rituximab.

P2860

Q33645793-364CB228-77D7-4B3B-ADCF-AA2E887ACC62 Q35780034-8D85ED05-A0E2-44F2-9F85-2E5C57699BB2

P2860

New insights into the mechanisms of action of radioimmunotherapy in lymphoma.

http://www.wikidata.org/entity/Q37222783

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on August 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

New insights into the mechanisms of action of radioimmunotherapy in lymphoma.

@en

New insights into the mechanisms of action of radioimmunotherapy in lymphoma.

@nl

type

label

New insights into the mechanisms of action of radioimmunotherapy in lymphoma.

@en

New insights into the mechanisms of action of radioimmunotherapy in lymphoma.

@nl

prefLabel

New insights into the mechanisms of action of radioimmunotherapy in lymphoma.

@en

New insights into the mechanisms of action of radioimmunotherapy in lymphoma.

@nl

P1433

Q37222783-800BEFAA-7533-4AD3-8BE8-CD93BE83FB8B

P1476

Q37222783-3555A621-6FD6-4E53-B9B8-E1C8B69CC787

P2093

Q37222783-5925E887-D01D-408F-812D-AD900FD4FD88

Q37222783-AE467714-7CA3-486D-99B9-CB837C49A696

P2860

Q37222783-02244FF7-CD64-464C-A417-4AE11D17BE62

Q37222783-0425D0D5-AB18-42CE-BD17-D0E43A6B108B

Q37222783-06810655-94EB-4771-A05C-C769A7A18B39

Q37222783-0AE8EE48-2957-4ECB-A360-7AF97674D067

Q37222783-11164632-5466-4295-848F-DD0CBAF01B8C

Q37222783-12310351-BC53-415B-8BCC-97E7C26D3F0C

Q37222783-131A84F2-DC9A-43BA-84EA-7840047822A5

Q37222783-18AA7E2D-6DA6-4C87-BBB8-EFC1A2F4C569

Q37222783-1B763C17-27C7-4D13-9445-A2318FF40ED3

Q37222783-322AA5A9-F52E-43C6-B306-D0A151DEFB6D

P304

Q37222783-121D8AE8-7A15-4DFB-878A-09B5FCAAE218

P31

Q37222783-8656398A-1AE2-445E-8321-9B57531405D5

P356

Q37222783-B8AD82D2-1469-4FE7-B485-841E84852A21

P433

Q37222783-81E82B8D-DE5C-4D1D-A60A-098880536E59

P478

Q37222783-AF48FB07-848C-4A19-9EAA-5194F1611BB3

P50

Q37222783-DCAB3A78-A15E-4956-8510-53E910B4D9AF

P577

Q37222783-E68E98B7-ABC8-4A33-8F02-9DE5D5D716AD

P698

Q37222783-1F00974F-39FD-45D4-BB5E-EF3403D99476

P356

P1433

Journal of Pharmacy and Pharmacology

P1476

New insights into the mechanisms of action of radioimmunotherapy in lymphoma

@en

P2093

Andrei Ivanov

http://www.w3.org/2001/XMLSchema#string

Ruth Swann

http://www.w3.org/2001/XMLSchema#string

P2860

The biology of CD20 and its potential as a target for mAb therapy

Coordinating ERK/MAPK signalling through scaffolds and inhibitors

Ibritumomab tiuxetan radioimmunotherapy for patients with relapsed or refractory non-Hodgkin lymphoma and mild thrombocytopenia: a phase II multicenter trial.

Treatment with ibritumomab tiuxetan radioimmunotherapy in patients with rituximab-refractory follicular non-Hodgkin's lymphoma.

Safety of yttrium-90 ibritumomab tiuxetan radioimmunotherapy for relapsed low-grade, follicular, or transformed non-hodgkin's lymphoma.

Maximum-tolerated dose, toxicity, and efficacy of (131)I-Lym-1 antibody for fractionated radioimmunotherapy of non-Hodgkin's lymphoma.

Clinical radioimmunotherapy.

The emerging role of radioimmunotherapy in haematological malignancies.

Pivotal study of iodine I 131 tositumomab for chemotherapy-refractory low-grade or transformed low-grade B-cell non-Hodgkin's lymphomas.

Zevalin: the first radioimmunotherapy approved for the treatment of lymphoma.

P304

987-998

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1211/JPP.60.8.0006

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

60

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18644192

http://www.w3.org/2001/XMLSchema#string